Call For Entries: International Bureau for Epilepsy and UCB Launch the 2011 Excellence in Epilepsy Journalism Award to Recognise Outstanding Reporting on Epilepsy

Intended for the use of UK media only’

BRUSSELS, Belgium, May 17, 2011 - The International Bureau for Epilepsy (IBE) and biopharmaceutical company
UCB today announced the launch of the 2011 Excellence in Epilepsy Journalism
Award. The award is a joint initiative to raise awareness about epilepsy
across the globe by recognising journalists who have excelled in reporting on
this often misunderstood condition.

Epilepsy is the most common, serious neurological condition, affecting
nearly 50 million people worldwide.1 Since it was established in 2009, the
annual Excellence in Epilepsy journalism award has recognised original and
informative reporting on epilepsy, attracting a growing number of
high-quality entries from around the world and drawing attention to
under-reported issues.

The Excellence in Epilepsy Journalism Award is open to journalists around
the globe, who can either submit their own work or be nominated by a third
party. There are three categories for entries - print, online and broadcast,
with one winner to be selected from each group. Submitted entries will be
judged by an independent panel of media experts and people with experience of
epilepsy. The panel will select articles or reports that are responsible,
informative, original and support the aim of raising awareness and
understanding of epilepsy. Entries can be about any aspect of epilepsy and
must have been published or broadcast between 30th October 2010 and 30th
November 2011.

Notes to Editors

Entry criteria

To find out more information or to download an entry or nomination form,
please visit:
www.ibe-epilepsy.org/downloads/Award%20Form%20Web%202011.pdf

Certain local restrictions may apply regarding this award and the award
is only available where not prohibited or restricted by local laws and
regulations.

References

1. www.who.int/mediacentre/factsheets/fs999/en/ [accessed 7th
March 2011]

About the IBE

Founded almost 50 years ago, the IBE is an organisation of laypersons and
professionals interested in the medical and non-medical aspects of epilepsy.
The IBE addresses such social problems as education, employment, insurance,
driving licence restrictions and public awareness, and supports its members
through a range of innovative and important initiatives aimed at improving
the quality of life of people with epilepsy and their families.
www.ibe-epilepsy.org

About UCB

UCB, Brussels, Belgium is a biopharmaceutical company dedicated to the
research, development and commercialization of innovative medicines with a
focus on the fields of central nervous system and immunology disorders.

Forward looking statement

This press release contains forward-looking statements based on current
plans, estimates and beliefs of management. Such statements are subject to
risks and uncertainties that may cause actual results to be materially
different from those that may be implied by such forward-looking statements
contained in this press release. Important factors that could result in such
differences include: changes in general economic, business and competitive
conditions, effects of future judicial decisions, changes in regulation,
exchange rate fluctuations and hiring and retention of its employees.

UK/11KP0014/May2011

For Further information: IBE: Ann Little, Executive Director, IBE, T +353-1-210-8850, ibedublin at eircom.net ; UCB: Nancy Nackaerts, External Communications, UCB, T +32-473-864-414, nancy.nackaerts at ucb.com ; Eimear O'Brien, Associate Director, Global CNS Communications UCB, T +32-2-559-9271, eimear.obrien at ucb.com .